Kyverna Therapeutics, Inc Common Stock

Price & Volume

Stats

52W Range	$1.78-$8.44
Market Cap	$336.3M
Shares Short	3M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	-$137.1M
Diluted EPS	-$3.72

News

Yahoo Finance • 16 days ago

Kyverna Therapeutics GAAP EPS of -$0.85 misses by $0.04

Yahoo Finance • 17 days ago

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Yahoo Finance • last month

Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025

Yahoo Finance • last month

Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025

About

CEO	Mr. Warner Biddle
Address	5980 Horton Street, Emeryville, CA, United States, 94608
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	129